Homems

  • Novel Multiple Sclerosis Biomarker to measure severity of disease, suggests study

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva to Present New Data Across Multiple NS Therapeutic Areas at AAN

    • April 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • National MS Society commits $14.2 Million to new MS research

    • April 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Genentech to Present New Data for Ocrevus and NS pipeline expansion at AAN

    • April 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMD Serono Highlights Commitment to Advance MS Treatment with Investigational Cladribine Tablets and Rebif® Data at AAN 2018

    • April 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Beta-interferon & Glatiramer acetate pose low infection risks to MS patients, study reinforces

    • April 13, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Eisai to distribute Biogen’s MS drugs in India

    • April 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mylan acquires rights for new MS drug

    • April 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mavenclad (cladribine) approved for Active RMS in UAE

    • April 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mother to fly to Mexico for Stem cell MS treatment

    • April 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more